Navigation Links
Genoptix Announces Participation at the Barclays Capital 2010 Global Healthcare Conference

CARLSBAD, Calif., March 15 /PRNewswire-FirstCall/ -- Genoptix, Inc. ( GXDX), a specialized laboratory services provider, today announced the Company's participation at the Barclays Capital 2010 Global Healthcare Conference at the Loews Miami Hotel in Miami, Fla. to be held March 23-24, 2010.  

Doug Schuling, EVP and CFO of Genoptix, will present at the conference on Tuesday, March 23, 2010 beginning at approximately 2:30 p.m. EDT, when he will provide an overview of the Company's specialized diagnostic laboratory services business, growth strategies and financial performance.

The presentation is expected to last approximately 25 minutes and will be web cast live through the "Investors" section of the Genoptix website at Those who would like to listen to the presentation should go to this site at least 15 minutes prior to the event to register, download and install any necessary software. An audio replay will be available for 30 days following the initial presentation web cast.

About Genoptix, Inc.

Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix's highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma. Founded in 1999, Genoptix is a member of the Nasdaq Select Global Market and the S&P SmallCap 600 Index and is headquartered in Carlsbad, California. For more information, please visit

Forward-Looking Statements

This press release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. Genoptix disclaims, however, any intent or obligation to update these forward-looking statements.

SOURCE Genoptix, Inc.

Back to top



SOURCE Genoptix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Genoptix Reports Continued Strong Growth for the Second Quarter and First Half of 2009
2. Genoptix, Inc. to Announce Second Quarter 2009 Financial Results
3. Genoptix Announces Participation at the 29th Annual William Blair Growth Stock Conference
4. Genoptix Announces Participation at the Bank of America and Merrill Lynch 2009 Annual Health Care Conference
5. Genoptix Reports Strong Growth for the First Quarter of 2009
6. Genoptix, Inc. to Announce First Quarter 2009 Financial Results
7. Genoptix Announces Participation at the Cowen and Company 29th Annual Health Care Conference
8. Genoptix Announces Participation at Barclays Capital Global Healthcare Conference
9. Genoptix Reports Strong Full-Year Financial Results for 2008 and Raises Guidance for 2009
10. Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference
11. Genoptix Reports Strong Financial Results for the Third Quarter and Raises Guidance for Full-Year 2008
Post Your Comments:
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... ... Leading pediatric oncology experts at Children’s National Health System will join ... International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by Jeffrey Dome, ... at Children’s National, and Stephen P. Hunger, M.D., Chief of the Division of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
(Date:10/12/2017)... ... 2017 , ... Farm Forward joins Bon Appétit ... institutions in announcing the launch of the Leadership Circle , a program ... raised for food. , Founding members of the Leadership Circle also include Airbnb’s ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
Breaking Medicine Technology: